Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Peake, M. D.
Right arrow Articles by Pearson, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peake, M. D.
Right arrow Articles by Pearson, M. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Age and Ageing 2003; 32: 171-177
© 2003, British Geriatrics Society

Research Paper

Ageism in the management of lung cancer

Michael D. Peake, Sandy Thompson1, Derek Lowe and Michael G. Pearson on behalf of the Participating Centres

Clinical Effectiveness and Evaluation Unit, Royal College of Physicians of London, London, UK
1 Current address: Postgraduate Medical Centre, Northwick Park Hospital, London, UK

Abstract

Background: age-related differences in the treatment of lung cancer patients have been reported in the past, but most previous studies have not recorded case-mix factors, nor have they studied the impact of such ageism on survival.

Methods: a questionnaire-based study of diagnostic and case-mix factors was carried out across 48 hospital Trusts in the UK between 1997 and 1998. We identified 1,652 patients and followed through with regard to their treatment and survival for 6 months after diagnosis.

Results: the median age of the population was 69 years, and for this analysis, was divided into three age groups: under 65 years, 65–74 and 75 years and over. There were significant inverse correlations between age and histological diagnosis, any active treatment and survival, even when corrected for case-mix factors and non-cancer causes of death. For example, the surgical resection rate in patients with confirmed non-small cell lung cancer with good performance status, no chronic obstructive pulmonary disease and limited disease was 37% in the younger patients compared with 15% in those 75 and over. The overall mortality rates at 6 months ranged from 42% in patients under 65 to 58% in the over 75s.

Conclusions: this national study of lung cancer care in the UK has shown large age-related differences in management and survival in patients with lung cancer, largely independent of case-mix factors. The reasons for this are complex but such under-treatment in the elderly may be one factor underlying the poor outcomes in lung cancer patients in the UK.

Keywords: lung cancer, ageism, elderly patients, treatment, survival


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 StrokeHome page
G. Saposnik, S. E. Black, A. Hakim, J. Fang, J. V. Tu, M. K. Kapral, and on behalf of the Investigators of the Registry of
Age Disparities in Stroke Quality of Care and Delivery of Health Services
Stroke, October 1, 2009; 40(10): 3328 - 3335.
[Abstract] [Full Text] [PDF]

Home page
 Age AgeingHome page
J. A. G. Blanco, I. S. Toste, R. F. Alvarez, G. R. Cuadrado, A. M. Gonzalvez, and I. J. G. Martin
Age, comorbidity, treatment decision and prognosis in lung cancer
Age Ageing, November 1, 2008; 37(6): 715 - 718.
[Full Text] [PDF]

Home page
 Age AgeingHome page
K. D. Palnum, P. Petersen, H. T. Sorensen, A. Ingeman, J. Mainz, P. Bartels, and S. P. Johnsen
Older patients with acute stroke in Denmark: quality of care and short-term mortality. A nationwide follow-up study
Age Ageing, January 1, 2008; 37(1): 90 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Age AgeingHome page
A. G. Rudd, A. Hoffman, C. Down, M. Pearson, and D. Lowe
Access to stroke care in England, Wales and Northern Ireland: the effect of age, gender and weekend admission
Age Ageing, May 1, 2007; 36(3): 247 - 255.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. M. Jackman, B. Y. Yeap, N. I. Lindeman, P. Fidias, M. S. Rabin, J. Temel, A. T. Skarin, M. Meyerson, A. J. Holmes, A. M. Borras, et al.
Phase II Clinical Trial of Chemotherapy-Naive Patients >= 70 Years of Age Treated With Erlotinib for Advanced Non-Small-Cell Lung Cancer
J. Clin. Oncol., March 1, 2007; 25(7): 760 - 766.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. M. Mery, A. N. Pappas, R. Bueno, Y. L. Colson, P. Linden, D. J. Sugarbaker, and M. T. Jaklitsch
Similar Long-term Survival of Elderly Patients With Non-small Cell Lung Cancer Treated With Lobectomy or Wedge Resection Within the Surveillance, Epidemiology, and End Results Database
Chest, July 1, 2005; 128(1): 237 - 245.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. T. Penson, K. J. Daniels, and T. J. Lynch Jr.
Too Old to Care?
Oncologist, June 1, 2004; 9(3): 343 - 352.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.